Pfizer closes penicillin department in Catania: 330 redundancies confirmed
Published
The pharmaceutical multinational Pfizer has confirmed the definitive closure of the penicillin department at its Catania plant. During a meeting at the Ministry of Enterprises and Made in Italy (MIMIT), the company also announced the start of the collective dismissal procedure for approximately 330 workers.
The decision concerns one of the most important production activities at the Sicilian plant. The department that produces penicillin will be permanently closed, so there will be no resumption of production. For the workers involved, the news represents a very difficult moment and one of great uncertainty about their professional future.
The case is being closely followed by institutions and trade unions, who are calling for solutions to protect employment in the Catania area. MIMIT, the ministry responsible for productive activities, took part in the discussion between the company and workers' representatives.
The affair highlights the situation of pharmaceutical industries present in Italy and their importance for the economy and for employment in the South. New meetings are scheduled in the coming days to discuss the details of the procedure and possible support measures for the people who will lose their jobs.
Sources: Fedaiisf
More Italy news
- ASE Technology's Revenue Rises 47.1% in October
- La Financière de l'Échiquier strengthens its technology sector with a new appointment
- Claude Code flaw: sensitive data at risk online
- Fiber optics in Italy: how the network that brings internet into homes really works
- Grande Sicilia Bets on Young People: "Generazione Autonomista" Meeting in Syracuse on December 5
- From Online Insults to Support: An Idea for Women in Politics
- Arms decree for Ukraine: tension in government, Giorgetti has not yet signed
- Valditara calls for withdrawal of Laterza history textbook: "It indoctrinates students"